Blood-pressure drugs are in the crosshairs of COVID-19 research

April 23, 2020
(Reuters) – Scientists are baffled by how the coronavirus attacks the body – killing many patients while barely affecting others.

But some are tantalized by a clue: A disproportionate number of patients hospitalized by COVID-19, the disease caused by the virus, have high blood pressure. Theories about why the condition makes them more vulnerable – and what patients should do about it – have sparked a fierce debate among scientists over the impact of widely prescribed blood-pressure drugs.  Read more